All Type of News
Reference price system to launch in 2 months.
It is very likely for the new NHI drug pricing system called "Reference Price System" to be enforced after the public hearing in 2 months to come, according to Minister Kim Sung-ho of MOHW in his press interview on Au...
Sales of foreign-invested pharmaceutical firmshit snag
After the implementation of a new system of separating drug dispensing from medical practice (SDP function), the majority of foreign-invested pharmaceutical firms have sharply boosted their market share in the domesti...
Pharmaceutical industry spent 285 billion won for R&D.
The total R&D expenditures last year in the pharmaceutical industry recorded at 284,800 million won including the facilities, showing about 95.2% up from the previous year according to the statistic data compiled by t...
25 items of Pfizer Korea are subject to suspension of manufacturing business
In line with the recent controversy on the mixed packaging of both Cardura(doxazosin mesylate) and Cofrel (benproperine phosphate), 25 items of Pfizer Korea including Norvasc (amlodipine besylate) will subject to the ...
Hospital pharmacy society to form juridical corporation.
The Korea Society of Hospital Pharmacy (hereinafter called Society) is trying to set up a juridical corporation, which will be, then, the 3rd event applied to the MOHW's establishment standards of juridical corporatio...
New KRPIA chairman stresses efficient cost of drugs
The Korea Research-based Pharmaceutical Industry Association (KRPIA) plans to rectify the public's negative reactions on high-priced drugs, while highlighting the notion that foreign-invested pharmaceutical firms in K...
Minimum drug pricing systemdraws varying reactions from domestic pharmaceutical industry
With the tentative one-year implementation of the minimum drug pricing system in favor of the lowest drug prices in the reimbursement calculation of health insurance drug charges, the domestic pharmaceutical industry ...
Pharmacies striving to handle inventory drugs
Despite the previous agreement among the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical Manufacturers Association (KPMA) and the Korea Drug Wholesaler Association (KDWA) last April that for a three-...
KFDA under establishment of policy think-tank.
The KFDA's administration seems to be transformed to cope with ever changing circumstances. To this end the KFDA plans to form a think-tank titled "the Pharmaceutical Affairs Administration Development Planning Team" ...
KNPA to change the name of neuropsychiatry department for better image in public
The Korea Neuropsychiatry Practitioners Association (KNPA) is launching its campaign to change the name of neuropsychiatry department.
In a recent survey of the people, the KNPA said that as a result of evaluating ...
